Today: 14 April 2026
Estée Lauder stock slips in premarket after 8.5% Monday slide as travel-retail worries creep back
3 March 2026
2 mins read

Estée Lauder stock slips in premarket after 8.5% Monday slide as travel-retail worries creep back

NEW YORK, March 3, 2026, 06:05 EST — Premarket

  • EL slipped roughly 2% in early premarket trading, following Monday’s 8.5% tumble.
  • Sentiment in the beauty sector has shifted, with peers flagging concerns about margins and ongoing turbulence in travel retail.
  • Eyes move next to the March 16 dividend payout, then the earnings release and call set for May 1.

Estée Lauder Companies Inc shares slipped another 2.2% Tuesday morning, extending Monday’s 8.5% drop. The stock was indicated near $98.00 ahead of the bell, from a $100.19 close. Monday’s session saw the price move between $99.98 and $106.95, with volume reaching 5.25 million shares. Pre-market action, which precedes the 9:30 a.m. ET open, tends to be volatile on lighter trading.

Investors are recalibrating expectations for prestige beauty stocks, with fresh uncertainty over what now counts as “normal” margins. On this day, Germany’s Beiersdorf trimmed its 2026 core operating margin target and pointed to headwinds in both U.S. retail and China’s travel retail channel. Shares tumbled more than 12%. “No growth and the potential for falling margins was a negative surprise,” one local trader told Reuters. Reuters

Travel retail is finding its way back into headlines. Travel stocks slid Monday after the U.S.-Israel flare-up with Iran rattled flight routes and sent oil higher. “Every airline is full and every flight is full,” noted Paul Charles, who runs the PC Agency travel consultancy. Extended flight disruptions can hit airport and duty-free sales—still crucial for beauty companies, even if shoppers keep spending elsewhere. Reuters

EL popped out in New York trading, shrugging off a mostly flat market. This didn’t feel like a minor slip—more of a sharp reset. That’s been the story with this stock in recent weeks.

Estée Lauder—behind brands like Clinique, M.A.C, and Jo Malone—last made headlines on Feb. 5, boosting its full-year outlook but falling short of Wall Street forecasts. The stock tumbled roughly 23% on the news. CEO Stéphane de La Faverie told Reuters the business was “navigating the complexity and volatility” in the U.S., while Evercore ISI’s Robert Ottenstein pointed out that U.S. market share gains failed to show up in retailer orders. The company stuck with its projection of a $100 million annual profit hit from tariffs and warned third-quarter margins would shrink by 50 basis points, or half a percentage point. Reuters

The same themes stick out for the stock—U.S. orders, China appetite, travel retail, and the next move on costs. No scheduled catalyst lines up this week, so the tape is left to its own devices at the open.

According to Monday’s filing, de La Faverie took possession of 5,787 vested restricted stock units, with 2,333 shares set aside for taxes instead of hitting the open market. Restricted stock units serve as equity-based compensation, transforming into actual shares once they vest.

The next payout from the company comes in at $0.35 per share, set for shareholders of record on Feb. 27 and slated to hit accounts March 16, per its dividend schedule. Short-term traders sometimes chase these dates, but lately the stock’s day-to-day moves have been much more pronounced.

But if travel disruptions drag on, the hit to duty-free sales could get worse — and things won’t improve if U.S. retailers remain conservative with orders through spring. Any steeper rise in fuel or raw material costs would further challenge the company’s efforts to defend its margins.

Estée Lauder’s fiscal third-quarter results land May 1, with a conference call set to follow. Investors will have their ears out for fresh details on tariffs, U.S. order momentum, and signs that travel retail demand is staying afloat.

Stock Market Today

  • USO ETF Sees $249 Million Inflow, Shares Outstanding Up Nearly 20%
    April 14, 2026, 11:34 AM EDT. The United States Oil Fund (USO) ETF reported a notable inflow of approximately $249.2 million, representing a 19.9% week-over-week increase in units outstanding from 16.6 million to 19.9 million. USO's share price last traded at $76.56, situated between its 52-week low of $60.87 and high of $83.41. The ETF's recent growth reflects increased investor demand, as new units creation requires purchasing underlying holdings, potentially affecting those markets. Tracking changes in ETF units helps gauge market interest and underlying asset movements. USO's inflows highlight rising confidence amid fluctuating oil prices.

Latest article

Amazon to Buy Globalstar in $11.6 Billion Deal to Challenge Starlink, Keep Apple Satellite Features Running

Amazon to Buy Globalstar in $11.6 Billion Deal to Challenge Starlink, Keep Apple Satellite Features Running

14 April 2026
Amazon will acquire Globalstar for about $11.6 billion, aiming to speed up its direct-to-device satellite services and compete with SpaceX’s Starlink. Globalstar shareholders can choose cash or Amazon stock, with 58% already approving the deal. The merger still requires regulatory approval and depends on Globalstar meeting certain operational targets. Globalstar shares rose 9%, Amazon gained 2.7% after the announcement.
Meta Builds AI Version of Mark Zuckerberg for Employees as AI Push Leaves Metaverse Behind

Meta Builds AI Version of Mark Zuckerberg for Employees as AI Push Leaves Metaverse Behind

14 April 2026
Meta is developing an AI version of CEO Mark Zuckerberg, trained on his image, voice, and public statements to interact with employees, the Financial Times reported. The company ended 2025 with 78,865 staff and expects 2026 capital spending of $115–$135 billion, mostly for AI infrastructure and talent. Reuters said Meta has shifted top engineers into a new Applied AI group as part of its internal AI push.
Johnson & Johnson Earnings Beat Estimates, J&J Raises 2026 Outlook Despite Stelara Slump

Johnson & Johnson Earnings Beat Estimates, J&J Raises 2026 Outlook Despite Stelara Slump

14 April 2026
Johnson & Johnson reported first-quarter revenue of $24.1 billion, up 9.9%, and adjusted earnings of $2.70 per share, both above analyst estimates. Sales of cancer drug Darzalex hit $4 billion, while Stelara fell 60% to $656 million. The company raised its 2026 outlook, nudging full-year sales guidance to $100.8 billion. J&J shares slipped 0.27% to $237.96 in early trading.
Lululemon stock price slides before the bell as founder Chip Wilson files fresh proxy push
Previous Story

Lululemon stock price slides before the bell as founder Chip Wilson files fresh proxy push

Nokia stock slips after Monday rally as Google Cloud, Nvidia deals keep MWC traders busy
Next Story

Nokia stock slips after Monday rally as Google Cloud, Nvidia deals keep MWC traders busy

Go toTop